Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation1

Guido Kobbe, Ulrich Germing, Manuel Aivado, Fabian Zohren, Dominik Schubert, Corinna Strupp, H. Pape, Gero Tenderich, Reiner K rfer, Rainer Storb,

Transplantation · 2002 · 14 citations · 10 references

Abstract

Allogeneic blood stem-cell transplantation using minimal conditioning is a new, promising treatment option for patients with hematologic malignancies after solid-organ transplantation.

References

10